Supriya Lifescience, a front-runner in speciality active pharmaceutical ingredients (API) and CDMO services in India, has penned an agreement with Kalinga Institute of Technology for the advancement of GelHeal, an innovative protein-based hydrogel aimed at skin regeneration and wound healing. This collaboration highlights the company’s commitment to addressing complex healthcare challenges by creating cost-effective and time-saving medical solutions.

GelHeal: A Breakthrough in Healing and Skin Regeneration

Designed to provide mechanical support and promote scar-free skin regeneration, GelHeal is a topical formulation that has the potential to significantly impact the treatment of various skin injuries, including third-degree wounds, diabetic foot ulcers, and post-surgery wounds. The hydrogel stands out for its multifaceted benefits, including infection prevention, moisture maintenance, and support for strain-less wound closure.

Advancing Healthcare Solutions

Dr. Satish Wagh, Founder and Chairman of Supriya Lifescience Ltd, emphasizes the company’s ongoing efforts in healthcare innovation. Following the development agreement for Quickblue, an oral cancer detection kit, Supriya Lifescience is now focused on bringing more pioneering products like GelHeal to the market. “We are looking forward to aiding more innovative products like GelHeal, the simplest and cheapest wound healing gel,” Dr. Wagh states.

Dr. Wagh also notes the strategic move into diversified healthcare solutions, leveraging the company’s established CDMO capabilities to deliver niche products. He envisions that initiatives like these will position Supriya Lifescience Ltd as an integrated healthcare provider.

  Dermatology, GelHeal, India, Kalinga Institute of Technology, Skin Regeneration Gel, Supriya Lifescience